RESEARCH ARTICLE


Homogenous Fluorescent Assays for Characterizing Small-Molecule Activators of AMP-Activated Protein Kinase (AMPK)



Laurie J Reichling, Steven M Riddle, Baigen Mei, Rica Bruinsma, Tony A Goossens, Kristin G Huwiler, Mark Maffitt, Alyssa M.G Newport, Xiao-Dong Qian, Carmen Ruttimann-Johnson, Kurt W Vogel*
Invitrogen Discovery Sciences, 501 Charmany Dr, Madison, WI 53719


Article Metrics

CrossRef Citations:
0
Total Statistics:

Full-Text HTML Views: 573
Abstract HTML Views: 445
PDF Downloads: 191
Total Views/Downloads: 1209
Unique Statistics:

Full-Text HTML Views: 305
Abstract HTML Views: 232
PDF Downloads: 127
Total Views/Downloads: 664



2008 Bentham Science Publishers Ltd.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.5/), which permits unrestrictive use, distribution, and reproduction in any medium, provided the original work is properly cited.

* Address correspondence to this author at the Invitrogen Discovery Sciences, 501 Charmany Dr, Madison, WI 53719, USA; E-mail: kurt.vogel@invitrogen.com
Invitrogen Corporation, 94/96 South Street, Hopkinton, MA 01748-221, USA


Abstract

AMP activated protein kinase (AMPK) is a key regulator of cellular metabolism. AMPK activity is modulated in part by binding of AMP to the γ-subunit of the kinase, which increases the activity of the catalytic α-subunit. Because increased AMPK activity in the liver and in skeletal muscle leads to increased fatty acid oxidation and decreased cholesterol and fatty acid biosynthesis, activators of AMPK are being sought for treatment of type-2 diabetes and other metabolic disorders. The unique mechanism of AMPK activation offers an opportunity to develop small molecules that directly upregulate AMPK activity, and there exists a need for simplified methods to identify and characterize small-molecules that show isoform-specific effects on AMPK. We have developed a suite of fluorescence-based assays to identify and characterize such compounds, and have used these to characterize and compare activity of recombinant AMPK α1β1γ1 and α2β1γ1 isoforms in response to small molecule activators and inhibitors.